| SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF NET LOSS PER SHARE |
The
following table summarizes the securities that were excluded from the diluted per-share computation for the periods presented because
their inclusion would have been anti-dilutive:
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF NET LOSS PER SHARE
| |
|
2026 |
|
|
2025 |
|
| |
|
Three Months Ended June 30, |
|
| |
|
2026 |
|
|
2025 |
|
| Warrants |
|
|
38,341,664 |
|
|
|
38,825,000 |
|
| Stock options |
|
|
4,618,750 |
|
|
|
3,602,500 |
|
| Stock options [Member] |
|
|
4,618,750 |
|
|
|
3,602,500 |
|
| Acquisition Stock Consideration Payable |
|
|
- |
|
|
|
- |
|
| Total |
|
|
42,960,414 |
|
|
|
42,427,500 |
|
| |
|
2026 |
|
|
2025 |
|
| |
|
Six Months Ended June 30, |
|
| |
|
2026 |
|
|
2025 |
|
| Warrants |
|
|
38,341,664 |
|
|
|
- |
1 |
| Stock options |
|
|
4,618,750 |
|
|
|
- |
1 |
| Stock options [Member] |
|
|
4,618,750 |
|
|
|
- |
1 |
| Acquisition Stock Consideration Payable |
|
|
- |
|
|
|
- |
1 |
| Total |
|
|
42,960,414 |
|
|
|
- |
1 |
| 1 |
|
For the six months ended June 30, 2025, the Company reported net income and its common stock equivalents were dilutive; accordingly, no securities were excluded as anti-dilutive for that period. The effect of those dilutive securities on the weighted average number of diluted shares is presented in the reconciliation below. |
|
| SCHEDULE OF COMPUTED BASIC AND DILUTED NET INCOME PER SHARE |
Because
the effect of the Company’s common stock equivalents was dilutive for the six months ended June 30, 2025, the following table reconciles
the weighted average shares used to compute basic and diluted net income per share for that period:
SCHEDULE
OF COMPUTED BASIC AND DILUTED NET INCOME PER SHARE
| |
|
Six Months Ended |
|
| |
|
June 30, 2025 |
|
| |
|
|
(in shares) |
|
| Weighted average shares outstanding – basic |
|
|
682,188,467 |
|
| Effect of dilutive warrants |
|
|
38,863,674 |
|
| Effect of dilutive stock options |
|
|
3,621,146 |
|
| Effect of dilutive acquisition stock consideration payable |
|
|
67,246,796 |
|
| Weighted average shares outstanding – diluted |
|
|
791,920,083 |
|
|